Hosted on MSN16m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Johnson & Johnson Tops Q4 EPS Forecasts
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
Daily45m
FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression
The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...
FDA approves J&J’s nasal spray for severe depression as stand-alone treatment
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...
WATCH: Sen. Jim Justice’s Bulldog ‘Babydog’ Arrives at U.S. Capitol in Personal Puppy Wagon
Babydog, 5, stole the show at the Republican National Convention last year as Justice, 73, addressed the crowd.
L.A.’s Record-Breaking 262-Day Dry Spell Is Finally Ending
The historic dry spell that fueled the devastating Los Angeles wildfires is expected to end this weekend. Forecasters expect light rain and mountain snow on Saturday, ending 262 days and counting ...